期刊論文| 1. | Liu, Jyh‐You、Lin, Hsi‐Hsun、Liu, Yung‐Ching(2008)。Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan。Clinical Infectious Diseases，46，1761-1768。   |
| 2. | Ng, Mei-Hing、Chou, Jen-Yu、Chang, Ta-Jen(2013)。High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan。Addictive Behaviors，38，2089-2093。 |
| 3. | Chen, Ding-Shinn(2019)。Taiwan commits to eliminating hepatitis C in 2025。Lancet Infectious Diseases，19，466-467。 |
| 4. | Wu, Grace Hui-min、Pwu, Raoh-fang、Chen, Shih-chung(20181200)。Achieving Hepatitis C Elimination in Taiwan--Overcoming Barriers by Setting Feasible Strategies。Journal of the Formosan Medical Association，117(12)，1044-1045。 |
| 5. | Li, Chia-Wen、Yang, Chia-Jui、Sun, Hsin-Yun(2018)。Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan。PLoS One，13。 |
| 6. | Razavi, Homie、Gonzalez, Yuri Sanchez、Yuen, Cammy、Cornberg, Markus(2020)。Global timing of hepatitis C virus elimination in high-income countries。Liver International，40(3)，522-529。 |
| 7. | Wu, Grace Hui‐Min、Pwu, Raoh‐Fang、Chen, Shih‐Chung、Chen, Ding‐Shinn(2020)。Taiwan is on track of accelerating hepatitis C elimination by 2025。Liver International，40，1506-1507。 |
| 8. | Razavi, Homie、Gonzalez, Yuri Sanchez、Yuen, Cammy、Cornberg, Markus(2020)。Response to Taiwan is on track of accelerating hepatitis C elimination by 2025。Liver International，40，1507。 |
| 9. | Abdelwadoud, Moaz、Mattingly, T. Joseph II、Seguí, Hemanuel Arroyo、Gorman, Emily F.、Perfetto, Eleanor M.(2021)。Patient centeredness in hepatitis C direct-acting antiviral treatment delivery to people who inject drugs: a scoping review。The Patient，14，471-484。 |
| 10. | Byrne, C.、Radley, A.、Inglis, S. K.(2020)。Reaching mEthadone users Attending Community pHarmacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV)。BMJ Open，10。 |
| 11. | Rapoud, D.、Quillet, C.、Pham Minh, K.(2020)。Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C)。BMJ Open，10。 |
| 12. | Afdhal, N.、Zeuzem, S.、Kwo, P.(2014)。Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection。The New England Journal of Medicine，370，1889-1898。 |
| 13. | Ferenci, P.、Bernstein, D.、Lalezari, J.(2014)。ABT-450/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV。The New England Journal of Medicine，370，1983-1992。 |
| 14. | Liang, T. J.、Ghany, M. G.(2014)。Therapy of hepatitis C: back to the future。The New England Journal of Medicine，370，2043-2047。 |
| 15. | Gamkrelidze, Ivane、Pawlotsky, Jean-Michel、Lazarus, Jeffrey V.(2021)。Progress towards hepatitis C virus elimination in high-income countries: an updated analysis。Liver International，41，456-463。 |
| 16. | Picchio, Camila A.、Valencia, Jorge、Doran, Jason(2020)。The impact of the COVID-19 pandemic on harm reduction services in Spain。Harm Reduction Journal，17。 |
| 17. | Buti, Maria、Domínguez-Hernández, Raquel、Casado, Miguel Angel(2021)。Impact of the COVID-19 pandemic on HCV elimination in Spain。Journal of Hepatology，74，1246-1248。 |
| 18. | Blach, Sarah、Kondili, Loreta A.、Aghemo, Alessio(2021)。Impact of COVID-19 on global HCV elimination efforts。Journal of Hepatology，74，31-36。 |
| 19. | Becker, W. C.、Fiellin, D. A.(2020)。When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis。Annals of Internal Medicine，173，59-60。 |
| 20. | Volkow, N. D.(2020)。Collision of the COVID-19 and addiction epidemics。Annals of Internal Medicine，173，61-62。 |
| 21. | Shih, Cheng-Chan、Chen, Yi、Shao, Shih-Chieh、Lai, Edward Chia-Cheng(2020)。Strategies to maintain persistence of opioid agonist therapy during the novel coronavirus pandemic in Taiwan。Drug and Alcohol Dependence，217。 |
| 22. | Chevaliez, S.(2019)。Strategies for the improvement of HCV testing and diagnosis。Expert Review of Anti-infective Therapy，17，341-347。 |
| 23. | Jayadevappa, R.(2017)。Patient-centered outcomes research and patient-centered care for older adults: a perspective。Gerontology and Geriatric Medicine，3。 |
| 24. | Crespo, J.、Lázaro, P.、Blasco, A. J.(2021)。Hepatitis C reflex testing in Spain in 2019: a story of success。Enfermedades Infecciosas y Microbiología Clínica，39，119-126。 |
| 25. | Huang, Chung-Feng、Wu, Pey-Fang、Yeh, Ming-Lun(2021)。Scaling up the in-hospital hepatitis C virus care cascade in Taiwan。Clinical and Molecular Hepatology，27，136-143。 |
| 26. | Saludes, V.、Antuori, A.、Folch, C.(2019)。Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia。International Journal of Drug Policy，74，236-245。 |